期刊文献+

阻断血管紧张素Ⅱ对动脉粥样硬化兔心肌CRP的表达的影响 被引量:2

Blocking the effects of angiotensin Ⅱ can decrease the expression of C-reactive protein in rabbit atherosclerotic myocardium
下载PDF
导出
摘要 目的探讨卡托普利和缬沙坦不同水平阻断血管紧张素Ⅱ(AngⅡ)对心肌C反应蛋白(Creactiveprotein,CRP)表达的影响。方法30只新西兰白兔随机分为4组:(A组)高脂饮食组,(B组)高脂饮食加卡托普利组,(C组)高脂饮食加缬沙坦组及(D组)对照组。喂饲10周后,放射免疫法测定血浆AngⅡ含量,取心肌组织用免疫组化方法测定CRP的表达。结果A组心肌CRP表达较D组明显升高(P<0.005)。B组和C组与A组相比,心肌CRP表达显著降低(P<0.05,P<0.025),与D组比差异无统计学意义,二者之间差异也无统计学意义。剔除C组数据后,血浆AngⅡ水平与心肌局部CRP表达存在显著相关性(r=0.804,P<0.0001)。结论AngⅡ与心肌局部组织CRP的表达有显著的相关性;卡托普利和缬沙坦可降低心肌局部CRP的表达,在减轻动脉粥样硬化炎症反应对心肌的损害方面,两药之间差异无统计学意义。 Objective To observe the effects of captopril and valsartan on decreasing the expression of C-reactive protein (CRP) in rabbits atherosclerotic myocardium. Methods Thirty male New Zealand white rabbits were divided into four groups randomly: (A) cholesterol group, (B) cholesterol + captopril-treated group, (C) cholesterol + valsartan-treated group and (D) control group. After 10 weeks, angiotensin Ⅱ (Ang Ⅱ ) level of plasma was evaluated by radioimmunoassay. The heart were harvested for immunohistochemistry measure of CRP. Results Compared with control group, the expression of myocardial CRP in A group increased significantly (P〈0.005). The levels of myocardial CRP in B and C groups was lower than that of A group (P〈0.05, P〈0.025 ). There were not difference between B and C groups and control group. The expression of myocardial CRP in B and C groups was identical. After eliminating the data of C group, the expression of myocardial CRP correlated positively with Ang Ⅱ level of plasma. Conclusion Plasma Ang Ⅱ correlated positvely with the expression of myocardial CRP. Captopril and valsartan could reduce myocardial CRP. There was not difference in the effects on reducing myocardial CRP between captopril group and valsartan group.
出处 《中国心血管病研究》 CAS 2006年第9期694-696,共3页 Chinese Journal of Cardiovascular Research
基金 山西省回国留学人员科研资助项目(200531)
关键词 C反应蛋白 心肌 血管紧张素Ⅱ 动脉硬化 C-reactive protein Myocardium Angiotensin Ⅱ Artheriosclerosis
  • 相关文献

参考文献8

  • 1[1]Brasier AR,Recinos Ⅲ A,Eledrisi MS.Vascular inflammation and the renin-angiotensin system.Arterioscler Thromb Vasc Biol,2002,22:1257-1266.
  • 2[2]Yasojima K,Schwab C,McGeer EG,et al.Generation of C-reactive protein and complement components in atherosclerotic plaques.Am J Pathol,2001,158:1039-1051.
  • 3[3]Kobayashi S,Inoue N,Ohashi Y,et al.Interaction of oxidative stress and inflammatory response in coronary plaque instability.Arterioscler Thromb Vasc Biol,2003,23:1398-1404.
  • 4[4]Strawn WB,Chappell MC,Dean RH,et al.Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.Circulation,2000,101:1586-1593.
  • 5[5]Ruiz-Ortega M,Lorenzo O,Rupérez M,et al.Angiotensin Ⅱ activates nuclear transcription factor κB through AT1 and AT2 receptors in cultured vascular smooth muscle cells.Circ Res,2000,86:1266-1272.
  • 6[6]Shieffer B,Schieffer E,Hilfiker-Kleiner D,et al.Expression of angiotensin Ⅱ and intedeukin 6 in human coronary atherosclerotic plaques.Circulation,2000,101:1372-1378.
  • 7[7]Burke AP,Tracy RP,Kolodgie F,et al.Elevated C-reactive protein values and atherosclerosis in sudden coronary death.Circulation,2002,105:2019-2023.
  • 8[8]Nijmeijer R,Lagrand WK,Lubbers YTP,et al.C-reactive protein activates complement in infarcted human myocardium.Am J Pathol,2003,163:269-275.

同被引文献30

  • 1聂永梅,陈槐卿,成敏,邓伊伶.兔动脉粥样硬化斑块处单核细胞趋化蛋白-1的表达[J].第三军医大学学报,2006,28(15):1566-1569. 被引量:5
  • 2于婕,毛节明,王广.急性冠状动脉综合征及介入术后再狭窄患者血浆中单核细胞趋化蛋白1水平的变化[J].中国组织工程研究与临床康复,2007,11(4):653-656. 被引量:1
  • 3徐荣丰,高大胜,王红雷.血清新蝶呤和单核细胞趋化蛋白-1在冠心病患者血清中的表达及意义[J].中国心血管病研究,2007,5(6):420-422. 被引量:13
  • 4Mine S,Okada Y,Tanikawa T,et al. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Bioehem Biophys Res Commun, 2006,344 : 780-785.
  • 5Kornowski R, Hong MK,Tio FO,et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointireal hyperplasia. J Am Coll Cardiol, 1998,31:224-230.
  • 6Selzman CH, Miller SA, Zimmerman MA, et al. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol, 2002,283 : H1455-1461.
  • 7Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin : a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun, 1993,192 : 553-560.
  • 8Imai Y, Shindo T, Maemura K, et al. Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arterioscler Thromb Vasc Biol, 2002,22 : 1310 - 1315.
  • 9Tsuruda T, Kato J, Matsui E, et al. Adrenomedullin alleviates not only neointimal formation but also perivascular hyperplasia following arterial injury in rats. Eur J Pharmacol, 2005,508 : 201-204.
  • 10Behon O, Byrne D, Kearney D, et al. Cyclooxygenase- 1 and -2- dependent prostacyclin formation in patients with atherosclerosis. Circulation, 2000,102 : 840-845.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部